DRUG · Unmapped registry intervention
ropinirole controlled-release (REQUIP CR) for RLS
Find medicine records ·
Find other trials using this name
Clinical trial
Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's
NCT00363727
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedOnset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson's Diseaseverified · MONDO: Parkinson disease
Parkinson Diseaseverified · MONDO: Parkinson disease
Dyskinesiasunresolved
Interventions
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
HoustonTexas, United States2ChicagoIllinois, United States2DallasTexas, United States2BirminghamAlabama, United States2TampaFlorida, United States2Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1MiamiFlorida, United States1San AntonioTexas, United States1SeattleWashington, United States1CincinnatiOhio, United States1PhoenixArizona, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00363727 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.